Re: Responseon Shareholders meeting...opty

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

optymystic

Rank: President [?]

Points: 18922 [?]

Votes: 159 Score: 3.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Responseon Shareholders meeting...opty

in response to

Re: Responseon Shareholders meeting...opty

ronran

posted on Jan 16, 2013 02:36PM

< If that is accurate, then the Markman in the ITC, and perhaps motion practice deadlines in the NDCA, are the focus.

Well, IMO, another successful Markman isn't going to cheer up disgruntled shareholders. I would hope that PTSC realizes that they need more meat on the bone than that. If not, then there really is no need to put it off.

Motion practice deadlines?

Re timing of the ASM. From what I just read it does appear that your understanding is correct.